Sabahattin Kaymakoglu

Summary

Publications

  1. ncbi Interferon-alpha2b induction treatment with or without ribavirin in chronic hepatitis C: a multicenter, randomized, controlled trial
    Hakan Senturk
    Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Dig Dis Sci 48:1124-9. 2003
  2. ncbi Alpha interferon and ribavirin combination therapy of chronic hepatitis D
    Sabahattin Kaymakoglu
    Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul University, Capa, 34390, Istanbul, Turkey
    Antimicrob Agents Chemother 49:1135-8. 2005
  3. ncbi Pneumatic balloon dilatation in primary achalasia: the long-term follow-up results
    Gungor Boztas
    Department of Internal Medicine, Gastroenterology Division, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Hepatogastroenterology 52:475-80. 2005
  4. ncbi Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B
    Sabahattin Kaymakoglu
    Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul University, Capa 34390, Istanbul, Turkey
    Dig Dis Sci 52:727-31. 2007
  5. ncbi Pegylated interferon Alfa-2b monotherapy and pegylated interferon Alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B
    Sabahattin Kaymakoglu
    Istanbul University, Department of Gastroenterohepatology, Istanbul Medical Faculty, Capa, Istanbul, Turkey
    Antimicrob Agents Chemother 51:3020-2. 2007
  6. ncbi Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy
    Filiz Akyuz
    1 Department of Gastroenterohepatology, Istanbul University, Istanbul Medical Faculty
    Acta Gastroenterol Belg 70:20-4. 2007
  7. ncbi Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey
    Yilmaz Cakaloglu
    Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul, Turkey
    Turk J Gastroenterol 19:104-8. 2008
  8. ncbi Intestinal metaplasia in portal hypertensive gastropathy: a frequent pathology
    Duygu Ibrisim
    Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Eur J Gastroenterol Hepatol 20:874-80. 2008
  9. ncbi What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis?
    Kadir Demir
    Department of Gastroenterohepatology, Istanbul University, Turkey
    Ann Hepatol 6:92-6. 2007
  10. ncbi Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?
    Binnur Pinarbasi
    Department of Gastroenterohepatology, Medical Faculty, Istanbul University, Istanbul, Turkey
    J Clin Gastroenterol 43:176-81. 2009

Detail Information

Publications44

  1. ncbi Interferon-alpha2b induction treatment with or without ribavirin in chronic hepatitis C: a multicenter, randomized, controlled trial
    Hakan Senturk
    Department of Internal Medicine, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
    Dig Dis Sci 48:1124-9. 2003
    ..005.) In conclusion, IFN induction treatment in combination with ribavirin is superior to IFN induction treatment alone in genotype 1 patients, and the SVR rate of 39% is encouraging...
  2. ncbi Alpha interferon and ribavirin combination therapy of chronic hepatitis D
    Sabahattin Kaymakoglu
    Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul University, Capa, 34390, Istanbul, Turkey
    Antimicrob Agents Chemother 49:1135-8. 2005
    ....
  3. ncbi Pneumatic balloon dilatation in primary achalasia: the long-term follow-up results
    Gungor Boztas
    Department of Internal Medicine, Gastroenterology Division, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Hepatogastroenterology 52:475-80. 2005
    ..Pneumatic dilatation is a safe and most effective treatment for achalasia. We analyzed the long-term results of pneumatic dilatation in primary achalasia by objective and subjective findings...
  4. ncbi Long-term results of interferon alpha monotherapy in patients with HBeAg-negative chronic hepatitis B
    Sabahattin Kaymakoglu
    Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul University, Capa 34390, Istanbul, Turkey
    Dig Dis Sci 52:727-31. 2007
    ..Nearly half of the patients with HBeAg-negative chronic hepatitis B responds to IFN-alpha at the end of therapy. Despite the high recurrence rates, response continues in about one third of patients after a mean of 59.5 months...
  5. ncbi Pegylated interferon Alfa-2b monotherapy and pegylated interferon Alfa-2b plus lamivudine combination therapy for patients with hepatitis B virus E antigen-negative chronic hepatitis B
    Sabahattin Kaymakoglu
    Istanbul University, Department of Gastroenterohepatology, Istanbul Medical Faculty, Capa, Istanbul, Turkey
    Antimicrob Agents Chemother 51:3020-2. 2007
    ..At the end of follow-up, virological response rates (HBV DNA levels of <400 copies/ml) were similar in the monotherapy (24%) and combination therapy (26%) groups...
  6. ncbi Lamivudine monotherapy and lamivudine plus interferon alpha combination therapy in HBeAg negative chronic hepatitis B not responding to previous interferon alpha monotherapy
    Filiz Akyuz
    1 Department of Gastroenterohepatology, Istanbul University, Istanbul Medical Faculty
    Acta Gastroenterol Belg 70:20-4. 2007
    ....
  7. ncbi Prevalence and clinical significance of SEN-H virus in chronic hepatitis B, C and delta infections in Turkey
    Yilmaz Cakaloglu
    Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul, Turkey
    Turk J Gastroenterol 19:104-8. 2008
    ..We aimed to determine the prevalence and clinical significance of SEN viruses- H in patients with chronic hepatitis C, B and delta in Turkey...
  8. ncbi Intestinal metaplasia in portal hypertensive gastropathy: a frequent pathology
    Duygu Ibrisim
    Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Eur J Gastroenterol Hepatol 20:874-80. 2008
    ..To compare the frequency of intestinal metaplasia (IM) in patients with portal hypertensive gastropathy (PHG) to the control group with functional dyspepsia...
  9. ncbi What is the reason of elevated alanine aminotransferase level in HBeAg negative patients with low viremia: NAFLD or chronic hepatitis?
    Kadir Demir
    Department of Gastroenterohepatology, Istanbul University, Turkey
    Ann Hepatol 6:92-6. 2007
    ..We aimed to evaluate the causes of elevated ALT levels in patients who are negative for hepatitis B e antigen (HBeAg) and HBV DNA (by hybridization) for at least 6 months...
  10. ncbi Are acquired hepatocerebral degeneration and hepatic myelopathy reversible?
    Binnur Pinarbasi
    Department of Gastroenterohepatology, Medical Faculty, Istanbul University, Istanbul, Turkey
    J Clin Gastroenterol 43:176-81. 2009
    ..Acquired hepatocerebral degeneration (AHD) and hepatic myelopathy (HM) are rare complications of chronic liver disease and are usually resistant to medical therapy...
  11. ncbi Prevalence and virological features of occult hepatitis B virus infection in female sex workers who work uncontrolled in Turkey
    Binnur Pinarbasi
    Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Liver Int 29:227-30. 2009
    ..There is little information about the prevalence of occult hepatitis B virus infection (OHBVI). We have investigated the prevalence and virological features of OHBVI among female sex workers (FSWs) in Istanbul...
  12. ncbi Etiological factors of duodenal and gastric ulcers
    Ahmet Uyanikoglu
    Istanbul University, Faculty of Medicine, Department of Gastroenterohepatology, Istanbul, Turkey
    Turk J Gastroenterol 23:99-103. 2012
    ..We aimed to determine the etiology of patients with duodenal and gastric ulcers...
  13. ncbi Terlipressin and albumin combination treatment in hepatorenal syndrome
    Ahmet Danalioglu
    Istanbul University, Istanbul Medical Faculty, Gastroenterohepatology Department, Turkey
    Hepatogastroenterology 50:ccciii-cccv. 2003
    ..Parameters associated with response to terlipressin+albumin and increased survival should be defined better in a large cohort of cirrhotic patients with HRS...
  14. ncbi The effects of rosiglitazone, metformin, and diet with exercise in nonalcoholic fatty liver disease
    Filiz Akyuz
    Department of Gastroenterohepatology Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey
    Dig Dis Sci 52:2359-67. 2007
    ..Diet with exercise seems to be superior to metformin and rosiglitazone. Decreasing treatment response at month 12 compared to month 6 may be due to fluctuations of ALT levels. Treatment response should be evaluated histologically...
  15. ncbi Electron microscopic findings in non-alcoholic fatty liver disease: is there a difference between hepatosteatosis and steatohepatitis?
    Emel Ahishali
    Department of Gastroenterohepatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
    J Gastroenterol Hepatol 25:619-26. 2010
    ..This study was designed to comparatively evaluate electron microscopic features of non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH)...
  16. ncbi Intrahepatic and peripheral T-cell responses in genotype 1b hepatitis C virus-infected patients with persistently normal and elevated aminotransferase levels
    Filiz Akyuz
    Department of Gastroenterohepatology, Istanbul University, Istanbul, Turkey
    World J Gastroenterol 11:7188-91. 2005
    ..To evaluate whether the cytokine responses in liver and serum differ in chronic hepatitis C patients with normal and high alanine aminotransferase (ALT) levels...
  17. ncbi Risk factors for the transmission of hepatitis C virus infection in the Turkish population
    Cetin Karaca
    Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Dig Dis Sci 51:365-9. 2006
    ..2%) patients, however, in 8 (1.6%) patients no risk factors could be found. In Turkey, the most common risk factor for the transmission of HCV infection is surgery, which can be preventable...
  18. ncbi Cyclosporin for severe ulcerative colitis attacks
    Ahmet Danalioglu
    Istanbul University, Istanbul School of Medicine, Gastroenterohepatology Department, Turkey
    Hepatogastroenterology 50:ccxcviii-ccc. 2003
    ..CONCLUSION: Cyclosporin-A therapy in severe ulcerative colitis that is refractory to steroids, provides initial remission in 80% of patients and allows 40% to retain their colon for 1 year...
  19. ncbi The role of thrombopoietin and spleen volume in thrombocytopenia of patients with noncirrhotic and cirrhotic portal hypertension
    Filiz Akyuz
    Departments of Gastroenterohepatology, Istanbul University, Istanbul Faculty of Medicine, Istanbul
    Turk J Gastroenterol 18:95-9. 2007
    ..To determine the role of thrombopoietin and spleen volume in thrombocytopenia diagnosed in cirrhotic and noncirrhotic portal hypertensive patients...
  20. ncbi Anticoagulant therapy and Budd-Chiari syndrome: is it successful?
    Filiz Akyuz
    Department of Gastroenterohepatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
    Hepatogastroenterology 58:900-3. 2011
    ..Anticoagulant therapy is an accepted treatment for Budd-Chiari syndrome (BCS). However, the natural course of untreated patients is unclear. We aimed to evaluate the efficacy of anticoagulant therapy on survival in BCS...
  21. ncbi Liver abscess as a rare complication of Crohn's disease: a case report
    Cetin Karaca
    Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Turk J Gastroenterol 15:45-8. 2004
    ..The radiological methods are very useful in diagnosis and treatment of liver abscess. In this paper, we present a patient with pyogenic liver abscess which developed in the course of Crohn's disease...
  22. ncbi Effect of proton pump inhibitor (PPI) treatment in obstructive sleep apnea syndrome: an esophageal impedance-pHmetry study
    Fatih Ermis
    Department of Gastroenterology, Istanbul University, Istanbul, Turkey
    Hepatogastroenterology 58:1566-73. 2011
    ..We first evaluated the role of reflux in OSAS with simultaneous polysomnography and impedance-pHmetry and then investigated whether the effect of proton pump inhibitor (PPI) treatment changes in these parameters...
  23. ncbi Decreased prohepcidin levels in patients with HBV-related liver disease: relation with ferritin levels
    Oya Yonal
    Department of Gastroenterohepatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
    Dig Dis Sci 55:3548-51. 2010
    ..We investigated whether serum prohepcidin is related to iron overload and perenchymal dysfuction in HBV-related liver disease...
  24. ncbi Is portal hypertensive enteropathy an important additional cause of blood loss in portal hypertensive patients?
    Filiz Akyuz
    Istanbul Medical Faculty, Department of Gastroenterology, Capa Istanbul, Turkey
    Scand J Gastroenterol 45:1497-502. 2010
    ..However, the clinical impact of these changes is unknown. In this study, we aimed to determine the additional cause of blood loss in portal hypertensive patients...
  25. ncbi A new agent for tumour necrosis factor-alpha inhibition: In vitro effects of dipyridamole in Crohn's disease
    Sule Poturoglu
    Department of Internal Medicine, Division of Gastroenterohepatology Istanbul University, Istanbul, Turkey
    Scand J Clin Lab Invest 69:696-702. 2009
    ..Our study aims to investigate the in vitro effects of dipyridamole (DP) on the TNF-alpha and interleukin-10 (IL-10) production in the intestinal mononuclear cells of CD patients...
  26. ncbi HFE gene mutation, chronic liver disease, and iron overload In Turkey
    Oya Yonal
    Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Dig Dis Sci 52:3298-302. 2007
    ..004). We conclude that C282Y mutation is very rare in Turkey. Iron overload is not related to H63D mutation but is positively correlated with biochemical activity and Child-Pugh score in chronic liver diseases...
  27. ncbi Occult HBV infection and YMDD variants in hemodialysis patients with chronic HCV infection
    Fatih Besisik
    Department of Internal Medicine, Hepatology Division, Istanbul University, Istanbul Medical Faculty, Capa, 34390 Istanbul, Turkey
    J Hepatol 38:506-10. 2003
    ....
  28. ncbi Second-line levofloxacin-based triple therapy's efficiency for Helicobacter pylori eradication in patients with peptic ulcer
    Fatih Ermis
    Department of Gastroenterology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    South Med J 104:579-83. 2011
    ..pylori eradication therapy in a country with a high rate of infection...
  29. ncbi Sexual transmission of HCV between spouses
    Veysel Tahan
    Marmara University School of Medicine, Department of Gastroenterology Altunizade, Istanbul, Turkey
    Am J Gastroenterol 100:821-4. 2005
    ..However, the seroprevalence rate of the spouses was still within the upper limit of our country population...
  30. ncbi A rare cause of hemosuccus pancreaticus: primary splenic artery aneurysm ruptured into pancreatic serous cystadenoma
    Binnur Pinarbasi
    Department of Internal Medicine, Division of Gastroenterohepatology, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
    Turk J Gastroenterol 19:57-63. 2008
    ..This is an interesting case diagnosed with multidisciplinary approaches...
  31. ncbi Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?)
    Sadakat Ozdil
    Istanbul University, Istanbul Medical Faculty, Department of Gastroenterohepatology, Turkey
    Hepatogastroenterology 51:768-70. 2004
    ..Evaluation of clinical, demographic and epidemiologic features of ulcerative colitis and therapy response of these patients...
  32. ncbi Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients
    Sabahattin Kaymakoglu
    Division of Gastroenterology, Istanbul Medical Faculty, Istanbul University, Istanbul, Turkey
    Dig Dis Sci 48:556-60. 2003
    ..8 mm Hg). These findings show that hepatopulmonary syndrome may occur in both liver cirrhosis and noncirrhotic portal hypertension and that portal hypertension is the predominant etiopathogenic factor related to hepatopulmonary syndrome...
  33. ncbi Congenital portal vein aneurysm associated with peliosis hepatis and intestinal lymphangiectasia
    Zeynel Mungan
    Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul University, Millet Cad 34390 Capa, Istanbul, Turkey
    Gastroenterol Res Pract 2009:479264. 2009
    ..Best of our knowledge, there is no such a case reported previously with the association of PVA, PH and IL. Therefore, we propose PVAPHIL syndrome to define this novel association...
  34. ncbi A case of Aeromonas hydrophila enteritis in the course of ulcerative colitis
    Emel Ahishali
    Istanbul Medical Faculty, Department of Gastroenterohepatology, Turkey
    Eur J Intern Med 18:430-1. 2007
    ..Clinical improvement was observed upon oral ciprofloxacin treatment. No clinical or laboratory activation of ulcerative colitis was detected during this infection...
  35. ncbi Efficacy and safety of Saccharomyces boulardii in prevention of antibiotic-associated diarrhoea due to Helicobacterpylori eradication
    Deniz Güney Duman
    Department of Gastroenterology, Marmara University, School of Medicine, Istanbul, Turkey
    Eur J Gastroenterol Hepatol 17:1357-61. 2005
    ..We aimed to evaluate the efficacy and safety of Saccharomyces boulardii in preventing antibiotic-associated diarrhoea in patients receiving antibiotics for H. pylori eradication...
  36. ncbi Eosinophilic esophagitis: case report
    Zeynel Mungan
    Department of Internal Medicine, Division of Gastroenterohepatology, Istanbul University, Istanbul Medical Faculty, Istanbul
    Turk J Gastroenterol 18:100-2. 2007
    ..The long-term prognosis of eosinophilic esophagitis is uncertain; however, data suggests a benign course. We herein present two eosinophilic esophagitis cases that were the first to be diagnosed in our clinic...
  37. ncbi Postprandial platelet-poor plasma 5-hydroxytryptamine concentrations during diarrhea and constipation periods of alternatingtype irritable bowel syndrome patients
    Fatma Sen
    Department of Internal Medicine, Istanbul University Faculty of Medicine, Istanbul, Turkey
    Turk J Gastroenterol 22:270-8. 2011
    ..Results of the two periods were compared with each other as well as with the results of the controls...
  38. ncbi Evaluation of malignancy risk and endoscopic follow up in achalasia: case report
    Filiz Akyuz
    Department of Gastroenterohepatology, Istanbul University, Istanbul Medical Faculty, Istanbul, Turkey
    Turk J Gastroenterol 17:46-9. 2006
    ..Cancer risk continues after surgical operation in achalasia, like in this case. In conclusion, endoscopic follow up is necessary for these patients even after surgical treatment...
  39. ncbi The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis
    Ipek Yonal
    Division of Hematology, Department of Internal Medicine, Medical Faculty, Istanbul University, Istanbul, Turkey
    J Thromb Thrombolysis 34:388-96. 2012
    ..Our results imply that JAK2V617F mutation screening should be an initial test for MPN in patients with SVT...
  40. ncbi Somatostatin and propranolol to treat small-for-size syndrome that occurred despite splenic artery ligation
    Ilgin Ozden
    Department of General Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey
    Exp Clin Transplant 5:686-9. 2007
    ..To the best of our knowledge, this is the first report of the successful treatment of small-for-size syndrome by somatostatin and propranolol in the clinical setting...
  41. ncbi Intestinal metaplasia of the gastric cardia: a study from Turkey
    Dinc Dincer
    Department of Gastroenterohepatology, Istanbul Medical Faculty, Istanbul, Turkey
    Hepatogastroenterology 49:1153-6. 2002
    ..We also re-evaluated the relation between intestinal metaplasia in the cardia and gastroesophageal reflux disease, smoking, alcohol history, H. pylori infection, Barrett's esophagus and intestinal metaplasia elsewhere in the stomach...
  42. ncbi Vanishing bile duct and Stevens-Johnson syndrome associated with ciprofloxacin treated with tacrolimus
    Gokhan Okan
    Gastroenterohepatology Department, Acibadem Bakirkoy Hospital, Istanbul, Turkey
    World J Gastroenterol 14:4697-700. 2008
    ..It is the first case of ciprofloxacin-induced VBDS successfully treated with tacrolimus. This case reminds physicians of the importance of drug reactions, their severity, techniques for diagnosis and methods of management...
  43. ncbi Coexistence of homozygous factor V Leiden mutation and antiphospholipid antibodies in two patients presented with Budd-Chiari syndrome
    Reyhan Diz-Kucukkaya
    Department of Internal Medicine, Istanbul Medical Faculty, The University of Istanbul, Turkey
    Haematologia (Budap) 32:73-7. 2002
    ..The interaction of antiphospholipid antibodies and factor V Leiden mutation in the pathogenesis of antiphospholipid syndrome and their contribution to Budd-Chiari syndrome are discussed...
  44. ncbi Rare complication of interferon alpha therapy: retinal vein thrombosis
    Filiz Akyuz
    Acta Gastroenterol Belg 68:394-5. 2005